Monogram Technologies Announces Q1 2025 Results Conference Call

Monogram Technologies Inc. (NASDAQ:MGRM) has scheduled a conference call on May 14, 2025, at 4:30 p.m. Eastern Time to discuss its first-quarter financial results and recent regulatory updates. The company will address its new FDA 510(k) Clearance for the Monogram mBôsTM TKA System and the approval to begin clinical trials in India. Ahead of the call, Monogram will issue a detailed press release.

Ben Sexson, CEO, and Noel Knape, CFO, will host the session, which will include a Q&A segment. The call can be accessed via the company's website or through a provided registration link. A live broadcast and subsequent replay will be available on Monogram's investor relations webpage.